Cancer is not one disease, and cancer treatment is never one decision. What is appropriate for a Stage 1 tumour in a 45-year-old with no comorbidities is entirely different from what is appropriate for the same tumour at Stage 3 with lymph node involvement, and different again for metastatic Stage 4 disease. Apollo Cancer Centre, Chennai, India's first NABH-accredited oncology hospital and the first in South Asia to introduce CyberKnife, TrueBeam STX, and, through Apollo Proton Cancer Centre, the only proton therapy facility in South Asia and the Middle East has built its reputation on precisely this principle: treatment selection is not based on what is available, but on what is appropriate for the specific tumour at its specific stage in each specific patient.
This guide maps the type of cancer treatment at Apollo Cancer Centre, Chennai to the cancer stage at which each is most relevant, and explains how international patients from Bangladesh, Nigeria, Kenya, the UAE, and elsewhere access this care.
The Foundation: How Apollo Cancer Centre Chennai Plans Treatment
Before any treatment decision is made at Apollo Cancer Centre, Chennai, every case is reviewed by a multidisciplinary Tumour Board consisting of medical, surgical, and radiation oncologists working alongside diagnostic consultants. The Tumour Board examines referred cases jointly and decides the best suitable line of treatment for each patient. Cancer therapy is personalised the board in association with the diagnostic consultants examines the case together and decides the best suitable line of treatment for each patient.
This Tumour Board structure is the most important institutional feature that distinguishes Apollo Cancer Centre from a general hospital with an oncology unit. It ensures that the decision about whether a patient needs surgery first, radiation first, or chemotherapy first is not made by a single specialist but by the full team whose collective expertise covers every modality available.
What Makes Apollo Cancer Centre, Chennai Different
Apollo Cancer Centre is India's first ISO certified healthcare provider, ranked among the top super specialty hospitals. It was the first oncology hospital in India and first hospital in Chennai city to be accredited by NABH. It was the first hospital in South-East Asia to introduce the 64 Slice PET-CT Scan. It was the first hospital in India to introduce CyberKnife and the first hospital in India to have all the latest radiotherapy equipment such as TrueBeam STX.
Powered by over 45 specialized oncologists, Apollo Cancer Centre serves patients from over 120 countries. It has performed over 10,000 successful bone marrow transplants and is a pioneer in minimally invasive and robotic surgeries.
Stage 1 and Stage 2: Curative Intent Treatment Options
Early-stage cancers, where the tumour is confined to the primary site or has spread only to immediately adjacent lymph nodes, carry the highest probability of cure. The treatment selected at Stage 1 and Stage 2 aims at complete elimination of the cancer, not just control.
Surgical Oncology for Early-Stage Disease
Surgery is the primary treatment for most Stage 1 and Stage 2 solid tumours where the cancer is resectable and no systemic spread has occurred. Complex tumour removals are skillfully performed by Apollo's highly trained and motivated surgical oncologists. Specialised surgeries including skull base, commando, liver resection, micro vascular reconstructions of flaps, extensive resection of hepatic and lung tumours, limb conserving surgery in bone tumours, laparoscopic surgery in staging and diagnosis are performed with high success rates. Apollo Cancer Centre has a state-of-the-art operating room with Pentero 900 high-definition microscope with both Yellow Fluorescence and IR 800 filters.
Robotic surgery is a key advancement at Apollo Cancer Centre for early-stage tumours requiring precision resection. Apollo Institutes of Robotic Surgery are committed to providing patients with an exceptional experience using cutting-edge treatment options. The da Vinci Surgical System enables surgeons to perform complex resections through tiny incisions, reducing blood loss, hospital stay, and recovery time compared to open surgery.
For breast cancer at Stage 1 and 2, Apollo offers breast-conserving surgery (lumpectomy) alongside sentinel lymph node biopsy, sparing women from full axillary dissection when the sentinel node is negative. For colorectal cancer, laparoscopic or robotic anterior resection and hemicolectomy achieve equivalent oncological outcomes to open surgery with faster recovery. For early lung cancer, video-assisted thoracoscopic surgery (VATS) lobectomy is performed as a minimally invasive alternative to open thoracotomy.
Radiation Therapy as Primary Treatment for Stage 1 and 2
For certain cancer types, radiation is the preferred curative treatment even at early stages, either because surgery would cause unacceptable functional loss or because the tumour location makes surgical resection technically difficult:
-
Early-stage head and neck cancers including laryngeal cancer, where radiation preserves voice function that laryngectomy would remove
-
Early-stage prostate cancer, where CyberKnife or TrueBeam STX stereotactic body radiation therapy (SBRT) achieves cure rates equivalent to surgical prostatectomy
-
Stage 1 non-small cell lung cancer in patients who cannot undergo surgery, where SBRT achieves local control rates of over 90 percent
-
Early-stage cervical cancer, where brachytherapy combined with external beam radiation is an alternative to radical hysterectomy
Apollo Cancer Centre Chennai was the first in India to introduce CyberKnife and TrueBeam STX, both of which deliver sub-millimetre precision radiation that is particularly valuable for early-stage tumours in or near critical structures.
Stage 3: Multimodal Treatment Combining Modalities for Local Control
Stage 3 cancers have extended beyond the primary site to involve regional lymph nodes or adjacent structures, but have not spread to distant organs. Treatment at Stage 3 almost always involves multiple modalities working in sequence or simultaneously.
Neoadjuvant Chemotherapy Before Surgery
For many Stage 3 solid tumours, the standard approach is neoadjuvant (pre-surgical) chemotherapy designed to shrink the tumour before the surgeon operates. A smaller, less adherent tumour is more likely to be completely resected, and the response to neoadjuvant chemotherapy provides direct information about the tumour's sensitivity to systemic agents. Apollo's medical oncology team coordinates the neoadjuvant chemotherapy sequence with the surgical plan, ensuring the timing between the last chemotherapy cycle and surgery is optimised for wound healing while minimising the risk of tumour regrowth.
The Medical Oncologists at Apollo Hospitals specialise in treating tumours through chemotherapy regimens. Various investigations are conducted to ascertain how the patient responds to a particular drug and to what extent that drug is beneficial.
Concurrent Chemoradiotherapy
For Stage 3 head and neck cancers, oesophageal cancer, cervical cancer, and selected lung and rectal cancers, concurrent chemoradiotherapy, chemotherapy administered during the same weeks as radiation to sensitise tumour cells to radiation is the evidence-based standard of care. Apollo Cancer Centre's integrated tumour board plans the concurrent regimen as a single coordinated protocol, not as separate decisions by independent departments.
TrueBeam STX for Advanced Local Disease
TrueBeam STX delivers radiation at six times the speed of conventional linear accelerators, reducing treatment times from over twenty minutes per session to under two minutes. This speed advantage is clinically meaningful for Stage 3 tumours where tumour motion during treatment delivery, such as from breathing in lung and liver cancers, produces geographic miss. Faster delivery reduces the window during which the tumour moves outside the planned radiation field, improving the accuracy of each treatment session.
Stage 4 and Metastatic Disease: Systemic and Targeted Therapy
Stage 4 cancer has spread to distant organs. Treatment at Stage 4 is primarily aimed at disease control, symptom management, and maximising quality of life, though for certain tumours with specific molecular profiles, meaningful long-term disease control or even complete response is achievable with modern targeted and immunotherapy agents.
Targeted Therapy Based on Molecular Profiling
Apollo Cancer Centre leads the way in personalised cancer treatment with advanced genomic testing. Genomic profiling of the tumour identifies actionable mutations that specific targeted agents can inhibit. For EGFR-mutant non-small cell lung cancer, osimertinib produces intracranial and systemic responses. For HER2-positive breast cancer, trastuzumab combinations produce significant disease control. For BRAF V600E-mutant melanoma and colorectal cancer, BRAF plus MEK inhibitor combinations are standard.
Apollo Cancer Centre Chennai performs next-generation sequencing panels on tumour tissue or circulating tumour DNA to identify the full landscape of actionable mutations before systemic treatment begins, ensuring targeted therapy is selected on the basis of the tumour's specific biology rather than its tissue of origin alone.
Immunotherapy
Immune checkpoint inhibitors including pembrolizumab, nivolumab, and ipilimumab are available at Apollo Cancer Centre Chennai for cancer types where immunotherapy has demonstrated significant benefit. PD-L1 testing is performed before immunotherapy initiation to identify patients most likely to respond. Combination immunotherapy regimens are used for high-grade melanoma, non-small cell lung cancer, renal cell carcinoma, and selected gastric and bladder cancers.
Proton Therapy for Metastatic Disease in Selected Cases
Apollo Proton Cancer Centre is the only facility of its kind in South Asia and the Middle East. Proton therapy delivers the radiation dose to the tumour target with minimal exit dose, significantly reducing radiation to surrounding healthy tissues compared to conventional photon radiation. For metastatic disease, proton therapy is used for brain metastases, spinal metastases causing neurological compromise, and liver metastases amenable to stereotactic treatment, where the precision advantage over conventional radiation reduces toxicity to adjacent critical structures. Apollo Proton Cancer Centre has treated patients from 147 countries around the world.
Bone Marrow Transplant for Haematological Malignancies
Apollo Cancer Centre has performed over 10,000 successful bone marrow transplants. For Stage 4 haematological cancers including multiple myeloma, relapsed diffuse large B-cell lymphoma, and high-risk leukaemia, autologous or allogeneic stem cell transplantation following high-dose conditioning chemotherapy remains the treatment most likely to achieve durable remission. Apollo Cancer Centre's bone marrow transplant programme, with over 10,000 procedures, is one of the largest in India.
Palliative and Supportive Oncology
For patients where curative treatment is not achievable, Apollo Cancer Centre's palliative oncology programme provides pain management, symptom control, psychological support, nutritional therapy, and end-of-life planning in a patient-centred framework. Palliative radiation for bone metastases, spinal cord compression, and superior vena cava obstruction provides significant symptom relief and is delivered on an outpatient basis in most cases.
Cancer Types Treated Across All Stages at Apollo Cancer Centre, Chennai
Apollo Cancer Centre treats all major cancer types across all stages within its organ-specific super-specialty service model:
-
Head and Neck Cancers: Skull base tumours, oral cavity, oropharynx, larynx, thyroid, salivary gland, nasopharynx
-
Breast Cancer: Stage 1 through Stage 4, including inflammatory breast cancer and metastatic HER2-positive disease
-
Lung Cancer: NSCLC and SCLC across all stages, including EGFR and ALK-targeted therapy
-
Gastrointestinal Cancers: Oesophageal, gastric, colorectal, hepatocellular carcinoma, pancreatic, and cholangiocarcinoma
-
Gynaecological Cancers: Cervical, endometrial, ovarian, and vulval cancers
-
Urological Cancers: Prostate, bladder, renal cell carcinoma, and testicular cancers
-
Haematological Malignancies: Leukaemia, lymphoma, and multiple myeloma with bone marrow transplant capability
-
Bone and Soft Tissue Sarcomas: Limb-conserving surgery and HYPERTEC targeted radiation for sarcomas
-
Neuro-Oncology: Brain tumours, spinal tumours, and brain metastases with CyberKnife and proton therapy
How Karetrip Connects International Cancer Patients to Apollo Cancer Centre, Chennai
Karetrip reviews each patient's pathology reports, staging scans, and prior treatment history before recommending Apollo Cancer Centre, Chennai, and coordinating access to the appropriate tumour board review and specialist team. From pre-travel imaging and pathology review through medical visa coordination, accommodation near Apollo Cancer Centre in Greams Road, Chennai, and post-treatment discharge documentation for continuation of systemic therapy at home, Karetrip manages the complete international patient journey.
Chat with our Medical care assistant, RUA, for quick guidance and support and take the first step toward a stage-appropriate cancer treatment plan at Apollo Cancer Centre, Chennai.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice, diagnosis, or a treatment recommendation. Cancer treatment decisions must be made by a qualified oncologist based on individual diagnosis, staging, and clinical assessment. Always consult a licensed specialist before making any treatment decision.